In eight of the 13 tumor types analyzed, high LAG-3 expression (as defined by >15 LAG-3+ tumor-infiltrating lymphocytes (TILs)) was found in ≥30% of the samples, with DLBCL having the highest LAG-3 expression. This evidence concerns the gene LAG3 and diffuse large B-cell lymphoma.